Triacetoxyperiodinane → 1-[(2S,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-oxo-tetrahydrofuran-2-yl]propyl acetate
Reaction equation
[C:1]([O:4][CH:5]([C@@H:8]1[CH2:12][C@@H:11]([OH:13])[C@H:10]([N:14]2[C:18]3[N:19]=[C:20]([NH2:24])[NH:21][C:22](=[O:23])[C:17]=3[S:16][C:15]2=[O:25])[O:9]1)[CH2:6][CH3:7])(=[O:3])[CH3:2].CC(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C=CC=CC1=2)=O>C1COCC1>[C:1]([O:4][CH:5]([C@@H:8]1[CH2:12][C:11](=[O:13])[C@H:10]([N:14]2[C:18]3[N:19]=[C:20]([NH2:24])[NH:21][C:22](=[O:23])[C:17]=3[S:16][C:15]2=[O:25])[O:9]1)[CH2:6][CH3:7])(=[O:3])[CH3:2]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of 1-[(2S,4R,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl acetate (compound 22a, 2.8 g, 7.6 mmol) in THF (100 mL) was added Dess-Martine periodinane (4.8 g, 11.3 mmol). After being stirred at room temperature for 2 hours, the resulting solution was filtered and the filtrate was concentrated in vacuo. The residue was purified by column chromatography on silica gel (eluting with 1:10 methanol in DCM) to afford 2.8 g crude product of 1-[(2S,5R)-5-(5-amino-2,7-dioxo-6H-thiazolo[4,5-d]pyrimidin-3-yl)-4-oxo-tetrahydrofuran-2-yl]propyl acetate (compound 22b). MS obsd. (ESI−) [(M−H)−]: 367.
Workup
- filtrationthe resulting solution was filtered
- concentrationthe filtrate was concentrated in vacuo
- customThe residue was purified by column chromatography on silica gel (eluting with 1:10 methanol in DCM)
Sources & evidence
- ORD record
- ord-0a4e26f289ae41db9fbfa5dd76196540
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09441008B2
Reaction notes
Loading…